Gemvax As

Ingvil Sæterdal

Jon Amund Eriksen

Mona Møller

Marianne Klemp Gjertsen

Gustav Gaudernack

Stein Sæbøe-Larsen

Gustay Gaudernack

Isolated peptides that are fragments of protein products arising from frameshift mutations in genes associated with cancer are disclosed. The isolated peptides of the invention are capable of eliciting T cell immunity against cells harboring genes with such frameshift mutations. Cancer vaccines and therapeutically effective compositions containing the peptides of the invention are also described.

Peptides

This invention relates to proteins or peptides that elicit T cell mediated immunity, and to cancer vaccines and compositions for anti-cancer treatment comprising such proteins or peptide fragments. This invention also relates to pharmaceutical compositions comprising the proteins or peptides and methods for generating T lymphocytes capable of recognizing and destroying tumor cells in a mammal. More specifically, a telomerase protein or peptide for use in a method of treatment or prophylaxis of cancer is provided. In a preferred embodiment, the method comprises generating a T cell response against telomerase.

Antigenic peptides derived from telomerase

Growing community of inventors

Oslo, Norway

Ingvil Sæterdal